Evidence map›Paper›PMID 33368376›Full record

ArticleMedical physics2021

Risks of feature leakage and sample size dependencies in deep feature extraction for breast mass classification.

Ravi K Samala, Heang-Ping Chan, Lubomir Hadjiiski, Mark A Helvie

Open access · bronzeAbstract read
In one paragraph

Article in Medical physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. BaselineFrontiers in oncology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Machine learning and new insights for breast cancer diagnosis.The Journal of international medical research · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ravi K SamalaDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Heang-Ping ChanDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Lubomir HadjiiskiDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Mark A HelvieDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · US

Funding

Advanced breast tomosynthesis reconstruction for improved cancer diagnosisR01CA214981 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHAN, HEANG-PING, FESSLER, JEFFREY A · 2018 to 2022
$2.3M
Digital Tomosynthesis Mammography: Computer-Aided Analysis of MassesR21CA120234 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHAN, HEANG-PING · 2006 to 2006
$216k
NCI NIH HHS R01 CA214981NIH HHS R01CA214981
6 · The paper itself

Abstract

purposeTransfer learning is commonly used in deep learning for medical imaging to alleviate the problem of limited available data. In this work, we studied the risk of feature leakage and its dependence on sample size when using pretrained deep convolutional neural network (DCNN) as feature extractor for classification breast masses in mammography.

methodsFeature leakage occurs when the training set is used for feature selection and classifier modeling while the cost function is guided by the validation performance or informed by the test performance. The high-dimensional feature space extracted from pretrained DCNN suffers from the curse of dimensionality; feature subsets that can provide excessively optimistic performance can be found for the validation set or test set if the latter is allowed for unlimited reuse during algorithm development. We designed a simulation study to examine feature leakage when using DCNN as feature extractor for mass classification in mammography. Four thousand five hundred and seventy-seven unique mass lesions were partitioned by patient into three sets: 3222 for training, 508 for validation, and 847 for independent testing. Three pretrained DCNNs, AlexNet, GoogLeNet, and VGG16, were first compared using a training set in fourfold cross validation and one was selected as the feature extractor. To assess generalization errors, the independent test set was sequestered as truly unseen cases. A training set of a range of sizes from 10% to 75% was simulated by random drawing from the available training set in addition to 100% of the training set. Three commonly used feature classifiers, the linear discriminant, the support vector machine, and the random forest were evaluated. A sequential feature selection method was used to find feature subsets that could achieve high classification performance in terms of the area under the receiver operating characteristic curve (AUC) in the validation set. The extent of feature leakage and the impact of training set size were analyzed by comparison to the performance in the unseen test set.

resultsAll three classifiers showed large generalization error between the validation set and the independent sequestered test set at all sample sizes. The generalization error decreased as the sample size increased. At 100% of the sample size, one classifier achieved an AUC as high as 0.91 on the validation set while the corresponding performance on the unseen test set only reached an AUC of 0.72.

conclusionsOur results demonstrate that large generalization errors can occur in AI tools due to feature leakage. Without evaluation on unseen test cases, optimistically biased performance may be reported inadvertently, and can lead to unrealistic expectations and reduce confidence for clinical implementation.

Indexed as

MammographyNeural Networks, ComputerAlgorithmsBreastHumansSample Sizebreast cancer classificationfeature leakagegeneralization errorpretrained DCNNsample size

Identifiers

PMID33368376
PMCPMC8601676
OpenAlexW3113493652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.